Matches in Wikidata for { <http://www.wikidata.org/entity/Q66027444> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q66027444 description "clinical trial" @default.
- Q66027444 description "ensayu clínicu" @default.
- Q66027444 description "klinisch onderzoek" @default.
- Q66027444 description "клінічне випробування" @default.
- Q66027444 name "A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia" @default.
- Q66027444 name "A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia" @default.
- Q66027444 type Item @default.
- Q66027444 label "A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia" @default.
- Q66027444 label "A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia" @default.
- Q66027444 prefLabel "A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia" @default.
- Q66027444 prefLabel "A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia" @default.
- Q66027444 P1050 Q66027444-2EFC6DE7-A3DD-420A-A0EE-54F4A8B15083 @default.
- Q66027444 P1132 Q66027444-5EE77882-4C0E-4C97-8AA1-EB052864BD11 @default.
- Q66027444 P1476 Q66027444-6C188A43-055A-4B94-A74B-B7A23466E7E9 @default.
- Q66027444 P17 Q66027444-745FC82E-4FF0-45E6-8AFC-39EE2EBC25C9 @default.
- Q66027444 P2899 Q66027444-8006A249-8567-470F-BD76-50DAA193C283 @default.
- Q66027444 P3098 Q66027444-D7284FAF-5833-4C7C-9BA7-2B4006AA98F2 @default.
- Q66027444 P31 Q66027444-6E549FCA-283D-43C8-AFC8-0E8D109BD81E @default.
- Q66027444 P4135 Q66027444-4FC26062-5894-4520-AC3D-B0CC0487F29D @default.
- Q66027444 P4844 Q66027444-36ECBD3F-E156-470D-B70E-CD84C619F04F @default.
- Q66027444 P580 Q66027444-BF3A6483-833E-4DA7-BA3F-F32EEB57C8D2 @default.
- Q66027444 P582 Q66027444-FE3EB19A-2BEE-46CE-A6BA-C662D479941B @default.
- Q66027444 P6099 Q66027444-D48C2207-42EB-48C0-8495-A2CA3CE565DD @default.
- Q66027444 P6153 Q66027444-ADEC7229-67DA-4D81-869A-BDF2619B0D19 @default.
- Q66027444 P8363 Q66027444-976F3C1E-B882-4713-B0D2-F208AD9DCF73 @default.
- Q66027444 P1050 Q41861 @default.
- Q66027444 P1132 "+369" @default.
- Q66027444 P1476 "A 10-12 Week Multicenter, Double-blind Study to Evaluate the Efficacy and Safety of the Combination of Valsartan (320 mg) and Simvastatin (80 mg) Compared to Valsartan (320 mg) and Simvastatin (80 mg) Monotherapies in Essential Hypertension and Hypercholesterolemia" @default.
- Q66027444 P17 Q30 @default.
- Q66027444 P2899 "+18" @default.
- Q66027444 P3098 "NCT00171093" @default.
- Q66027444 P31 Q30612 @default.
- Q66027444 P4135 "+75" @default.
- Q66027444 P4844 Q7912612 @default.
- Q66027444 P580 "2004-09-01T00:00:00Z" @default.
- Q66027444 P582 "2006-01-01T00:00:00Z" @default.
- Q66027444 P6099 Q42824827 @default.
- Q66027444 P6153 Q507154 @default.
- Q66027444 P8363 Q78089383 @default.